Treatment of Severe Chronic Graft-Versus-Host Disease with Decidual Stromal Cells and Tracing with Indium Radiolabeling February 17, 2022February 10, 2022 by admin
Xeno-immunosuppressive properties of human decidual stromal cells in mouse models of alloreactivity in vitro and in vivo February 17, 2022February 10, 2022 by admin
Frontline Science: Placenta-derived decidual stromal cells alter IL-2R expression and signaling in alloantigen-activated T cells February 17, 2022February 10, 2022 by admin
Preclinical Toxicity Evaluation of Clinical Grade Placenta-Derived Decidua Stromal Cells February 18, 2022November 19, 2019 by admin
Long-Term Follow-Up of a Pilot Study Using Placenta-Derived Decidua Stromal Cells for Severe Acute Graft-versus-Host Disease February 18, 2022October 10, 2019 by admin
Placenta-Derived Decidua Stromal Cells for Treatment of Severe Acute Graft-Versus-Host Disease February 18, 2022April 20, 2018 by admin
Safety and Side Effects of Using Placenta-Derived Decidual Stromal Cells for Graft-versus-Host Disease and Hemorrhagic Cystitis February 18, 2022July 11, 2017 by admin
Decidual Stromal Cells Promote Regulatory T Cells and Suppress Alloreactivity in a Cell Contact-Dependent Manner February 18, 2022October 1, 2013 by admin
Fetal membrane cells for treatment of steroid-refractory acute graft-versus-host disease February 18, 2022March 30, 2013 by admin
Expansion and activation kinetics of immune cells during early phase of GVHD in mouse model based on chemotherapy conditioning February 18, 2022January 10, 2010 by admin
